化合物对HSV-1的抗病毒潜力:体外研究
Shahrzad Zangooie1, Reza Ghanbari2, Farid Azizi Jalilian1
1Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Antiviral therapy
|September 23, 2024
概括
奎尔塞丁和多克索鲁比辛在对抗HSV-1感染方面表现有前途. 奎尔素具有抗炎功效,而多克索鲁比是一种抗癌药物,为简单疹病毒1型提供了潜在的新治疗途径.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 简单疹病毒1型 (HSV-1) 仍然是一个重要的人类病原体.
- 研究针对HSV-1的新型治疗剂至关重要,特别是对于耐药菌株.
- 类化合物因其抗病毒潜力而受到探索.
研究的目的:
- 评估体内基化合物的疗效,包括多克索鲁比辛和奎尔塞丁,对HSV-1.
- 为了比较这些化合物的抗病毒活性与已知的治疗方法,如阿西克洛维尔.
- 评估这些化合物在不同治疗环境中的潜力.
主要方法:
- 使用MTT测定对维罗细胞的化合物的细胞毒性评估.
- 用特定药物治疗HSV-1.
- 使用TCID50%和qPCR对收集的超水生物进行病毒定位.
- 在不同时间点对病毒DNA标位的分析.
主要成果:
- 克洛维尔,多克索鲁比辛和奎尔塞丁在病毒定位上显示出显著的变化 (p < .05).
- 复星对病毒定位没有显著影响.
- qPCR证实,使用多克索鲁比辛和奎尔塞丁,HSV-1 DNA标位显著降低,尽管随着时间的推移,水平上升.
- doxorubicin 和 quercetin 在特定度下显示出显著的病毒标位下降,与阿西克洛维尔相当.
结论:
- 奎尔赛丁 (62和125微米) 显著降低了HSV-1的感染力,并且在某些时间点显示出与阿西克洛维尔 (10微米) 相比的优异降低.
- 奎尔西的抗炎性质将其定位为治疗严重的HSV-1疾病的潜在治疗方法,如疹脑炎.
- 多克索鲁比在无毒度 (2和8μM) 时显示出显著的HSV-1抑制,这表明它在瘤性病毒疗法中对癌症治疗具有实用性.
相关概念视频
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


